CompletedNot Applicable

Occult Obscure Gastrointestinal Bleeding

Italy60 participantsStarted 2017-02-01

Plain-language summary

To test the activity of a polyglucosamine (PG) together with a Standard Management protocol (SM) on the occult and obscure gastrointestinal bleeding (OGIB) and the clinical symptoms in patients suffering from colonic diverticulitis (CD).

Who can participate

Age range55 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects aged between 55 to 65 years (males and females). * CD diagnosis. * DICA (Diverticular Inflammation and Complication Assessment) class DICA 2 or DICA 3. * OGIB positive to Hemoccult Sensa Fecal Occult Blood Procedure. Exclusion Criteria: * Subjects with Class DICA \> 3. * Therapy with mesalazine antibiotics and probiotics. * Cancer of any type (a part from benign polyposis), * Alcoholism. * Parkinsonism. * Alzheimer's Disease. * Severe depression. * Drug addiction.

What they're measuring

Change of Occult bleeding

Timeframe: Baseline - 1 month - 3 months

Trial details

NCT IDNCT03464539

SponsorBlymum Srl

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-05-15

View on ClinicalTrials.gov More Gastrointestinal Bleeding trials